Search Login Register

anecortave acetate Summary

Description: derived from cortisone (11 OH replaced by 9-11 double bond) and retains some of the angiostatic effects of cortisone, but none of the anti-inflammatory capabilities; structure in first source

Also Known As: 4,9(11)-pregnadien-17alpha,21-diol-3,20-dione-21-acetate

Networked: 34 relevant articles (9 outcomes, 9 trials/studies) for this Bio-Agent

Key Diseases for which anecortave acetate is Relevant

  1. Macular Degeneration (Age-Related Maculopathy) : 6 outcomes 4 studies in 18 results
  2. Choroidal Neovascularization : 2 outcomes 3 studies in 10 results
  3. Neoplasms (Cancer) : 1 outcome 1 study in 5 results
  4. Retinoblastoma (Glioblastoma, Retinal) : 1 outcome 1 study in 3 results
  5. Retinal Neoplasms : 1 outcome in 2 results
Show All >>

Drugs Related to anecortave acetate

  1. beta Subunit Luteinizing Hormone
  2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
  3. Gelatinases
  4. Retinaldehyde (Retinal)
  5. ranibizumab (Lucentis)
  6. verteporfin (Visudyne)
  7. ROP
  8. Brain Natriuretic Peptide (Natrecor)
  9. Carboplatin (JM8)
  10. Yttrium
Show All >>

Therapies Related to anecortave acetate

  1. Intraocular Injections
  2. Photochemotherapy (Photodynamic Therapy)
  3. Light Coagulation
  4. Injections
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.